Results 31 to 40 of about 8,190,661 (311)

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

BMC Cancer, 2018
Background Non-small-cell lung cancer (NSCLC) accounts for 85% of all lung cancers and is associated with a poor prognosis. Afatinib is an irreversible ErbB family blocker recommended in clinical guidelines as a first-line treatment for NSCLC which ...
Ping-Tee Tan, Mohamed Ismail Abdul Aziz, Fiona Pearce, Wan-Teck Lim, David Bin-Chia Wu, Kwong Ng   +5 more
doaj   +1 more source

Study protocol: maintaining preventive care during public health emergencies through effective coordination

Implementation Science Communications, 2023
Background Screening lies at the heart of preventive care. However, COVID-19 dramatically disrupted routine screening efforts, resulting in excess mortality not directly attributable to COVID-19.
Sylvia J. Hysong, Traber Davis Giardina, Jennifer Freytag, Richard SoRelle, Daniel R. Murphy, Jeffrey A. Cully, Yvonne H. Sada, Amber B. Amspoker   +7 more
doaj   +1 more source

Cost, Effectiveness, and Cost-Effectiveness [PDF]

Circulation: Cardiovascular Quality and Outcomes, 2009
Pluck the goose so as to obtain the most feathers with the least hissing . — —Jean-Baptiste Colbert, Minister of Finance to King Louis XIV of France Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose
George A, Diamond, Sanjay, Kaul
openaire   +2 more sources

The effectiveness and cost-effectiveness of respite for caregivers of frail older people [PDF]

, 2007
The proportion of frail elderly people in the industrialized world is increasing. Respite care is a potentially important way of maintaining the quality of life for these people and their caregivers.
Arksey, Artaso Irigoyen, Baumgarten, Buchner, Burch, Census 2001., Chapko, Clark, Conlin, Covinsky, Derogatis, Donaldson, Feinberg, Fisher, Gaugler, Gaugler, Grant, Grundy, Hedrick, Hirst, Holm, Johnson, Kosloski, Kosloski, Lawton, Lee, Lund, Maher, Montgomery, Montgomery, Montgomery, Montgomery, Montgomery, Niebuhr, Pinquart, Quayhagen, Robertson, Robertson, Rockwood, Rockwood, Rockwood, Sörensen, Undertaking Systematic Reviews of Research on Effectiveness., Walston, Wan, Wells, Wills, Wishart, Yin, Zank, Zarit   +50 more
core   +1 more source

Evaluating the care received by patients with oesophago-gastric (OG) cancer: the richer picture provided by linked datasets

International Journal of Population Data Science, 2017
Objectives The national oesophago-gastric cancer audit evaluates the care given to patients with OG cancer diagnosed in England and Wales, identifying areas for local services to improve and so achieve better patient outcomes.
Christian Brand, Mira Varagunam, Georgina Chadwick, David Cromwell   +3 more
doaj   +1 more source

Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?

Cost Effectiveness and Resource Allocation, 2021
Background The CardioMEMS® sensor is a wireless pulmonary artery pressure device used for monitoring symptomatic heart failure (HF). The use of CardioMEMS was associated with a reduction of hospitalizations of HF patients, but the acquisition cost could ...
Andrea Alcaraz, Carlos Rojas-Roque, Daniela Prina, Juan Martín González, Andrés Pichon-Riviere, Federico Augustovski, Alfredo Palacios   +6 more
doaj   +1 more source

Should Research Ethics Encourage the Production of Cost-Effective Interventions? [PDF]

, 2016
This project considers whether and how research ethics can contribute to the provision of cost-effective medical interventions. Clinical research ethics represents an underexplored context for the promotion of cost-effectiveness.
A Briggs, A Fleischman, A Rid, AD Paltiel, AJ London, AJ London, AM Garber, AS Kesselheim, C Grady, CC Denny, D Barnbaum, D Mortimer, D Wendler, DA Hyman, DB Resnik, DJ Torgerson, DM Dimichele, DR Buchanan, E Frank, ED Prentice, EE Roughead, EJ Emanuel, EJ Emanuel, EJ Emanuel, EJ Emanuel, EJ Emanuel, F Baylis, FA Lederle, G Yamey, GA Cohen, GR Wilensky, H Grabowski, HF Lynch, HG Frankfurt, HJ Curzer, I Rudan, J Cohen, J Dowie, J Harris, J McMahan, JA Tobert, JC Lindsey, JW Berg, L Bojke, LP Garrison Jr, M Angell, M Limb, MF Drummond, MJ Mehlman, MS Mano, N Daniels, NMP King, NMP King, PA Ubel, PJ Neumann, PJ Neumann, PR Orszag, PR Orszag, PT Menzel, PT Menzel, PT Menzel, R Dresser, RA Epstein, RA Rettig, RA Spinello, RK Lie, RL Fleurence, S Batt, S Joffe, S Palmer, S Thomson, S Woods, SE Weinberger, SK Shah, T Fojo, T Hurka, T Schrecker, TJ Zywicki, U Schüklenk, WC Black, Z Kmietowicz   +80 more
core   +1 more source

Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: a population-based case–control study, Spain, 2023/24 season

Eurosurveillance
Background Respiratory syncytial virus (RSV) causes substantial morbidity in infants 
the Nirsevimab Effectiveness Study Collaborators
doaj   +1 more source

Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer

BMC Health Services Research, 2020
Background The IMpassion130 trial demonstrated that adding atezolizumab to nanoparticle albumin-bound (nab)-paclitaxel improved the survival of patients with untreated, advanced, programmed death ligand 1 (PDL1)-positive triple-negative breast cancer ...
Lee Cheng Phua, Soo Chin Lee, Kwong Ng, Mohamed Ismail Abdul Aziz   +3 more
doaj   +1 more source

Assessing the ability of an instrumental variable causal forest algorithm to personalize treatment evidence using observational data: the case of early surgery for shoulder fracture

BMC Medical Research Methodology, 2022
Background Comparative effectiveness research (CER) using observational databases has been suggested to obtain personalized evidence of treatment effectiveness.
John M. Brooks, Cole G. Chapman, Sarah B. Floyd, Brian K. Chen, Charles A. Thigpen, Michael Kissenberth   +5 more
doaj   +1 more source